Back to Bills
HOUSE-BILL 5187119th Congress

HOUSE-BILL 5187: H.R.5187 - To establish in the Department of Defense a program to support the expansion of domestic bioindustrial manufacturing capacity.

Introduced: September 8, 2025
Status: Referred to Committee
R.for.R

AI-Powered Summary

Generated by AI Analysis

HOUSE-BILL 5187 establishes a program aimed at providing funding and support to private entities engaged in bioindustrial manufacturing, impacting individuals as employees, stakeholders, and consumers. The legislation addresses economic rights related to private enterprise, property rights, and due process in the allocation of awards, invoking the government's powers under the Commerce Clause and the Necessary and Proper Clause. Constitutional concerns include potential favoritism in the award process, equal protection issues, and the extent of government involvement in private industry, balanced against goals of promoting general welfare and national security. Key provisions include competitive award allocations, eligibility criteria, oversight and reporting requirements, and the potential for job creation and economic growth in the bioindustrial sector, which could benefit individuals and communities. Implementation will require adherence to these criteria and oversight mechanisms, with a focus on ensuring accountability and fostering economic development in the targeted sector.

Demographic Impact Analysis

AI Demographics Analysis

Summary

Overall Constitutional Implications

The bill's focus on expanding domestic bioindustrial manufacturing has the potential to create economic opportunities; however, it also raises serious concerns about equal access and the fair distribution of resources. The implications for individual rights are significant, particularly for marginalized groups who may not have equal access to the benefits of the program.

Key Individual Rights Affected

  • Equal Protection under the law
  • Due Process rights related to eligibility and decision-making
  • Health and Safety rights concerning biomanufactured products

Constitutional Provisions

  • 14th Amendment - Equal Protection Clause
  • 5th Amendment - Due Process Clause

Potential Constitutional Challenges

  • Disparities in access to economic opportunities could lead to legal challenges based on equal protection violations.
  • Lack of transparency in the awarding process may result in due process claims from individuals who feel unfairly treated.

Summary

While HOUSE-BILL 5187 aims to bolster the bioindustrial sector and create jobs, its implementation could lead to unequal access to resources and opportunities, particularly affecting vulnerable demographic groups. The bill's provisions must be scrutinized to ensure compliance with constitutional protections, particularly regarding equal protection and due process rights.

Constitutional Analysis

R.for.R

This bill has been analyzed for constitutional compliance using AI-powered analysis of constitutional principles and precedents.

Analysis generated using AI-powered review of constitutional principles and legal precedents.

Take Action

Text 50409

💡 How to use:

These links will start a conversation with ResistBot. When prompted, mention H.R. 5187 to reference this bill.

Contact Your Representatives

Write to YOUR elected officials about this bill

Rate This Bill

Sign in to save a private rating for this bill and track your civic engagement over time.

Sign In Free

Timeline

September 8, 2025

Bill Introduced

Current

Referred to Committee

June 12, 2026

Last Updated

Ask the Constitutional AI About This Bill

Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.

Sign In Free to Chat